Editors: Atta-ur-Rahman, FRS , M. Iqbal Choudhary

Frontiers in Anti-Cancer Drug Discovery

Volume 6

eBook: US $99 Special Offer (PDF + Printed Copy): US $181
Printed Copy: US $131
Library License: US $396
ISSN: 2451-8395 (Print)
ISSN: 1879-6656 (Online)
ISBN: 978-1-68108-150-2 (Print)
ISBN: 978-1-68108-149-6 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810814961150601

Introduction

"Frontiers in Anti-Cancer Drug Discovery" is an eBook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

The sixth volume of the series features chapters on several topics including:

  • - Monocarboxylate transporters as anti-cancer drug targets
  • - Interferon α-2b treatment for hepatocellular carcinoma
  • - Anthracyclines in cancer therapy
  • - Magnetosomes and tumor therapy
  • - and more.
Indexed in: Book Citation Index, Science Edition, BIOSIS Previews, EMBASE, EBSCO, Ulrich's Periodicals Directory.

Contributors

Editor(s):
Prof. Atta-ur-Rahman, FRS
University of Cambridge
Kings College
Cambridge
UK


Prof. M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi-75270
Pakistan




Contributor(s):
Beatriz de las Heras
Faculty of Pharmaceutical Sciences
Universidad Complutense de Madrid (UCM)
Madrid
Spain


Brian I. Carr
Liver unit, Department of Gastroenterology, Tel-Aviv Medical Center and the Sackler Faculty of Medicine
Tel-Aviv University
Tel-Aviv
Israel


Céline Pinheiro
Life and Health Sciences Research Institute (ICVS), School of Health Sciences
University of Minho
Braga
Portugal
/
ICVS/3B’s-PT Government Associate Laboratory
Braga/Guimarães
Portugal
/
Barretos School of Health Sciences
Dr. Paulo Prata – FACISB
Barretos, São Paulo
Brazil
/
Molecular Oncology Research Center
Barretos Cancer Hospital
Barretos, São Paulo
Brazil


Edouard Alphandéry
Nanobacterie SARL, 36 boulevard Flandrin, 75116
Paris
France
/
Institute of Mineralogy and Condensed Matter Physics (IMPMC)
Pierre and Marie Curie University (UPMC)
4 place Jussieu, 75005
Paris
France


Fátima Baltazar
Life and Health Sciences Research Institute (ICVS), School of Health Sciences
University of Minho
Braga
Portugal
/
ICVS/3B’s-PT Government Associate Laboratory
Braga/Guimarães
Portugal


Filipa Morais-Santos
Life and Health Sciences Research Institute (ICVS), School of Health Sciences
University of Minho
Braga
Portugal
/
ICVS/3B’s-PT Government Associate Laboratory
Braga/Guimarães
Portugal


Juan Pablo Parody
Institute of Experimental Physiology (IFISE-CONICET), Faculty of Biochemistry and Pharmacological Sciences
National University of Rosario
Suipacha 570, 2000
Rosario
Argentina


Julieta Afonso
Life and Health Sciences Research Institute (ICVS), School of Health Sciences
University of Minho
Braga
Portugal
/
ICVS/3B’s-PT Government Associate Laboratory
Braga/Guimarães
Portugal


Kazunari K Yokoyama
Center for Stem Cell Research, Center for Environmental Research
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University
100 Shin-Chuan 1st Road, Kaohsiung 804
Taiwan


Kenly Wuputra
Center for Stem Cell Research, Center for Environmental Research
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University
100 Shin-Chuan 1st Road, Kaohsiung 804
Taiwan


Mehrdad Asghari Estiar
Department of Medical Genetics, School of Medicine
Tehran University of Medical Sciences
Tehran
Iran


Liane Rabinowich
Liver unit, Department of Gastroenterology, Tel-Aviv Medical Center and the Sackler Faculty of Medicine
Tel-Aviv University
Tel-Aviv
Israel


Liat Mlynarsky
Liver unit, Department of Gastroenterology, Tel-Aviv Medical Center and the Sackler Faculty of Medicine
Tel-Aviv University
Tel-Aviv
Israel


Lidia Mazur
Department of Experimental Hematology
Jagiellonian University in Krakow
Gronostajowa 9, 30-387
Kraków
Poland


Małgorzata Opydo-Chanek
Department of Experimental Hematology
Jagiellonian University in Krakow
Gronostajowa 9, 30-387
Kraków
Poland


María Cristina Carrillo
Institute of Experimental Physiology (IFISE-CONICET), Faculty of Biochemistry and Pharmacological Sciences
National University of Rosario
Suipacha 570, 2000
Rosario
Argentina


María Paula Ceballos
Institute of Experimental Physiology (IFISE-CONICET), Faculty of Biochemistry and Pharmacological Sciences
National University of Rosario
Suipacha 570, 2000
Rosario
Argentina


Ming-Ho Tsai
Center for Stem Cell Research, Center for Environmental Research
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University
100 Shin-Chuan 1st Road, Kaohsiung 804
Taiwan


Oren Shibolet
Liver unit, Department of Gastroenterology, Tel-Aviv Medical Center and the Sackler Faculty of Medicine
Tel-Aviv University
Tel-Aviv
Israel


Ricardo Amorim
Life and Health Sciences Research Institute (ICVS), School of Health Sciences
University of Minho
Braga
Portugal
/
ICVS/3B’s-PT Government Associate Laboratory
Braga/Guimarães
Portugal


Sara Granja
Life and Health Sciences Research Institute (ICVS), School of Health Sciences
University of Minho
Braga
Portugal
/
ICVS/3B’s-PT Government Associate Laboratory
Braga/Guimarães
Portugal


Shigeo Saito
Saito Laboratory of Cell Technology
Yaita, Tochigi 329-1571
Japan
/
SPK Co., Ltd. Aizuwakamatsu
Fukushima 965-0025
Japan


Sonsoles Hortelano
Unidad de Terapias Farmacológicas. Área de Genética Humana. Instituto de Investigación de Enfermedades Raras (IIER)
Instituto de Salud Carlos III
Madrid
Spain


Vera Miranda-Gonçalves
Life and Health Sciences Research Institute (ICVS), School of Health Sciences
University of Minho
Braga
Portugal
/
ICVS/3B’s-PT Government Associate Laboratory
Braga/Guimarães
Portugal